Načítá se...

Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis

This study aimed to investigate the long-term outcomes of sulfonylurea (SU) use in patients with T2DM and compensated liver cirrhosis. From January 1, 2000, to December 31, 2012, we selected the data of 3781 propensity-score-matched SU users and nonusers from Taiwan’s National Health Insurance Resea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Yen, Fu-Shun, Lai, Jung-Nien, Wei, James Cheng-Chung, Chiu, Lu-Ting, Hwu, Chii-Min, Hou, Ming-Chih, Hsu, Chih-Cheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7735585/
https://ncbi.nlm.nih.gov/pubmed/33315940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0243783
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!